First Clinical Trial Of
First Three Parent Baby Born in 2016
--Sharing is Caring--

First Clinical Trial Of “Three Parent Baby” By Embryotools

In 2016 Worlds first “Three Parent Baby” was born by making use of genetic material from three people. It’s a novel technique invented to refrain the newborn child to inherit any disease via his or her mothers mitochondrial DNA. Under this technique mitochondria from one woman’s egg is taken along with the nucleus of another’s, the combination of which is then fertilized by sperm and then implanted into the uterus. It has been a controversial fertility treatment procedure since then. It is also known as a “mitochondrial replacement technique” or “three-person IVF”.

In the latest announcement, a Spanish company –  Embryotools have declared that they will have conducted their first clinical trial involving the three parent embryo technique to combat infertility. A 32-year-old woman has conceived under the same project. She is the one among 25 other women enrolled under the program for whom embryo has been successfully planted.

Co-founder of Embryotools – Nuno Costa-Borges stated that this could revolutionize the infertility treatment industry and may bring a new era in the field of IVF. He said that this procedure could give the patients chances of having a child genetically related to them.

Embryotools in collaboration with a fertility specialist at a clinic in Athens – Institute of Life. are studying 25 women under 40 years of age enrolled under the program. It includes only those women who have minimum two failed IVF attempts in the past. Since the procedure is banned in Spain the clinical trial was conducted in Greece after seeking approval from the Greek National Authority of Assisted Reproduction.

See Also
An Indian diagnostic Test Included in Global TB Programme By WHO

The research team at Embryotools via a technique called maternal spindle transfer to extract the nucleus from a donor egg and replace it with the nucleus taken from the intended mother’s egg. The donor egg thus obtained retains its healthy mitochondria. The remaining procedure remains the same to that of a general IVF process.

Earlier in 2015 UK was the first country to approve the usage of this technique but only in urgent conditions where the couples have a higher risk of delivering a genetically defected baby.

It is to be noted that this controversial procedure remains banned in many countries inlcuing the United States on the grounds that the DNA introduced in the embryo from the third parent will form genetic alterations that could run up to numerous generations to come.

Upload Your Resume' / CV to BioTecNika Talent Pool

Download This Notification
Perfection is her hobby, Reliability is a synonym, Editing is her passion, Excellence is her Goal, Tactfulness is in her genes, Yellow is her Fav color. Preety is the name of the Professional on whom entire BioTecNika relies when it comes to its website. A Gold Medalist in Biotech from SRM University, Chennai with a 9.9 CGPA ( was awarded the Gold Medal by Honorable Prime Minister of India Shri Narendra Modi , as seen in the pic ), She decided to join forces with BioTecNika to ensure India's largest BioSciences Portal expands its reach to every city in India. She has redesigned the new avatar of BioTecNika from scratch and heads the most dynamic, vibrant and well informed Online Team at Biotecnika Info Labs Pvt Ltd